If any controlled substance appears in the listed bulk database, please ignore it, as we do not supply or offer controlled substances.
Brivanib Alaninate-D4
100% accuracy
of data
24/7 scientific
support
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

Brivanib Alaninate-D4

● In Stock

Catalogue No.:DVE001527
CAS No.:N/A
Mol. Weight:445.49 g/mol

Additional information on Brivanib Alaninate-D4

Parent drug

Brivanib

IUPAC Name

(R)-1-((4-((4-Fluoro-2-methyl-1H-indol-5-yl)oxy)-5-methylpyrrolo[2, 1-f][1, 2, 4]triazin-6-yl)oxy)propan-2-yl alaninate-2, 3, 3, 3-d4

Pharmacopoeial Synonyms

N/A

Other Synonyms

N/A

Description

Brivanib Alaninate-D4 is a deuterium-labeled analog of Brivanib commonly utilized as an internal standard in analytical and pharmacokinetic research. This stable isotope-labeled compound improves the accuracy of mass spectrometry and liquid chromatography enabling precise quantification of Brivanib in biological samples. Ideal for researchers and laboratories Brivanib Alaninate-D4 ensures reliable analysis in therapeutic drug monitoring pharmacokinetic studies and metabolic research.

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
This field is hidden when viewing the form
Products quotation
Name
Url
 
This field is hidden when viewing the form
This field is hidden when viewing the form